[1]
Y. He and M. Lei, “p21-Activated Kinases Present a New Drug Target for Hypertrophic Cardiomyopathy”, IJDDP, vol. 2, no. 3, pp. 79–86, Sep. 2023. doi: 10.53941/ijddp.2023.100006.